Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

Fig. 2

Hospitalization according to Hydroxychloroquine Exposure from Date of Confirmed SARS-CoV-2 Infection. Cumulative prevalence of hospitalization among mildly symptomatic COVID-19 patients according to outpatient exposure to hydroxychloroquine from date of polymerase chain reaction confirmed infection with SARS-CoV-2 in propensity matched cohort. HCQ = hydroxychloroquine

Back to article page